Inhibrx Biosciences Inc. ( INBX) - Stock Earnings
INBX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
INBX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -32.8 million USD | — USD |
| 2026Q1 | -33.4 million USD | — USD |
| 2026Q2 | -36.7 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INBX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -241.4 million USD | 1.8 million USD |
| 2024 | 1.7 billion USD | 200000 USD |
| 2025 | -140.1 million USD | 1.3 million USD |
| 2026 Est. | — | — |
INBX
Price: $90.50
52 week price:
Earnings Per Share: -9.27 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 275430
Market Capitalization: 1.4 billion